Loading...
Fresenius SE & Co. KGaA
FSNUF•PNK
HealthcareMedical - Care Facilities
$50.29
$12.56(33.29%)
Fresenius SE & Co. KGaA (FSNUF) Financial Performance & Statements
Review Fresenius SE & Co. KGaA’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-2.09%
↓ 2.09%
Operating Income Growth
55.91%
↑ 55.91%
Net Income Growth
179.29%
↑ 179.29%
Operating Cash Flow Growth
-42.57%
↓ 42.57%
Operating Margin
8.65%
↑ 8.65%
Gross Margin
24.48%
↑ 24.48%
Net Profit Margin
1.91%
↑ 1.91%
ROE
2.20%
↑ 2.20%
ROIC
5.49%
↑ 5.49%
Fresenius SE & Co. KGaA (FSNUF) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Fresenius SE & Co. KGaA stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $5.63B | $5.37B | $5.46B | $5.70B |
| Cost of Revenue | $4.21B | $4.003B | $4.24B | $4.30B |
| Gross Profit | $1.42B | $1.36B | $1.22B | $1.41B |
| Gross Profit Ratio | $0.25 | $0.25 | $0.22 | $0.25 |
| R&D Expenses | $177.00M | $170.00M | $155.00M | $139.00M |
| SG&A Expenses | $733.00M | $701.00M | $803.00M | $708.00M |
| Operating Expenses | $946.00M | $871.00M | $958.00M | $847.00M |
| Total Costs & Expenses | $5.16B | $4.87B | $5.20B | $5.14B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $108.00M | $115.00M |
| Depreciation & Amortization | $255.00M | $265.00M | $322.00M | $291.00M |
| EBITDA | $724.00M | $757.00M | $587.00M | $850.00M |
| EBITDA Ratio | $0.13 | $0.14 | $0.11 | $0.15 |
| Operating Income | $469.00M | $492.00M | $265.00M | $559.00M |
| Operating Income Ratio | $0.08 | $0.09 | $0.05 | $0.10 |
| Other Income/Expenses (Net) | -$68.00M | -$77.00M | -$107.00M | -$145.00M |
| Income Before Tax | $401.00M | $415.00M | $158.00M | $444.00M |
| Income Before Tax Ratio | $0.07 | $0.08 | $0.03 | $0.08 |
| Income Tax Expense | $130.00M | $96.00M | $170.00M | $125.00M |
| Net Income | $240.00M | $326.00M | -$373.00M | $278.00M |
| Net Income Ratio | $0.04 | $0.06 | -$0.07 | $0.05 |
| EPS | $0.38 | $0.58 | -$0.66 | $0.49 |
| Diluted EPS | $0.38 | $0.58 | -$0.66 | $0.49 |
| Weighted Avg Shares Outstanding | $563.24M | $562.07M | $565.15M | $563.24M |
| Weighted Avg Shares Outstanding (Diluted) | $563.24M | $562.07M | $565.15M | $563.24M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan